Does the use of CELOX™ PPH for postpartum haemorrhage reduce the need for surgical therapy including hysterectomy? A databased historical cohort study.
Biele C, Radtke L, Kaufner L, Hinkson L, Braun T, Henrich W, Dückelmann AM. J Perinat Med. 2022; 50(8):1078-1086.
Retrospective cohort study (n=666)
- Assessment of the effectiveness of CELOX™ PPH in comparison with balloon tamponade, and medical therapy only
- Groups were compared in terms of therapy success, side-effects, and the primary outcome was the need for surgical measures (e.g., hysterectomy)
- No significant differences in the need for surgical therapy between groups.
- CELOX™ PPH group had significantly fewer hysterectomies compared to the balloon tamponade group.
- Following the introduction of CELOX™ PPH, the incidence of PPH-related hysterectomies was significantly reduced by 77.8%.
- No adverse events related to CELOX™ PPH
- CELOX™ PPH is easy to use and cost-effective compared to alternative devices.